Obiettivo
BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and generalizable guidelines and techniques to enhance immunosafety of novel vaccines from pre-development to post-marketing surveillance. A compact interlocking structure provides efficient and cost-effective goal delivery, while offering the full spectrum of functionality and capacity to match the needs for predictive biomarkers and models of inflammation/autoimmunity and clinical events classification. A Technology Core has transcriptomics, genotyping, proteomics, metabolomics and data mining, with depth and capacity to discover, validate and distribute novel biomarkers. A Models Core has a full range of ex vivo/in vivo murine, small animal and non-human primate models of inflammation and biomarker discovery, with advanced immunology and imaging. A Clinical Core has capability to safely and efficiently distribute clinical studies of vaccine immunosafety from small intensive trials to large-scale studies of adult, paediatric and other populations. A Populations Core has population-scale biobank discovery, clinical cohorts (with globalisation capability, autoimmune, chronic, inflammatory and infectious disease groups), large-scale genotyping and sequencing, and a safely accessible central database for online analyses of large datasets. A Regulatory Core with expertise to synthesise outputs to generate and disseminate classifications, guidelines, reference standards for vaccine development, and inform EFPIA activities. A Management Core with track record of successful public-private projects ensures Cores interoperate to maximise discovery - validation - application - re-discovery cycles, to deliver project goals on time, within budget, while maximising interactions with other actors (EFPIA, FDA, EMA).
Campo scientifico
- natural sciencesbiological scienceszoologymammalogyprimatology
- medical and health scienceshealth sciencesinfectious diseases
- natural sciencescomputer and information sciencesdata sciencedata mining
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
Invito a presentare proposte
IMI-JU-03-2010
Vedi altri progetti per questo bando
Meccanismo di finanziamento
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinatore
53100 SIENA
Italia
Mostra sulla mappa
Partecipanti (21)
GU2 7XH Guildford
Mostra sulla mappa
80539 Munchen
Mostra sulla mappa
Partecipazione conclusa
L35QA LIVERPOOL 3
Mostra sulla mappa
75015 PARIS 15
Mostra sulla mappa
SW7 2AZ LONDON
Mostra sulla mappa
53100 Siena
Mostra sulla mappa
76705 Rehovot
Mostra sulla mappa
412 96 GOTEBORG
Mostra sulla mappa
Partecipazione conclusa
SW1W 9SZ London
Mostra sulla mappa
3584 CS Utrecht
Mostra sulla mappa
Partecipazione conclusa
10117 Berlin
Mostra sulla mappa
9000 Gent
Mostra sulla mappa
405 30 Goeteborg
Mostra sulla mappa
Partecipazione conclusa
101 Reykjavik
Mostra sulla mappa
2300 Kobenhavn S
Mostra sulla mappa
1330 Rixensart
Mostra sulla mappa
69007 Lyon
Mostra sulla mappa
1060 Bruxelles / Brussel
Mostra sulla mappa
53100 Siena Si
Mostra sulla mappa
LS2 7UE Leeds
Mostra sulla mappa
SW17 0RE London
Mostra sulla mappa